Feb 4 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 448 mln 414 mln 770 mln
(+8.1 pct) (+6.3 pct) (+27.7 pct)
Operating loss 136 mln loss 230 mln loss 107 mln
Recurring loss 232 mln loss 299 mln loss 154 mln
Net loss 243 mln loss 303 mln loss 162 mln
EPS loss 26.14 yen loss 32.61 yen loss 17.42 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T